 LONDON and NEW YORK,, Nov. 05, 2020 GLOBE NEWSWIRE -- MeiraGTx Holdings plc Nasdaq: MGTX, a vertically integrated, clinical stage gene therapy company, today announced financial results for the third quarter ended September 30, 2020 and provided an update on recent clinical development and business progress. 